medicine

Germany has called on Israel to guarantee the delivery of humanitarian aid to Gaza, adding to international pressure over the worsening humanitarian situation in the territory. The appeal from Berlin underscores growing concern among European governments about access for food, medicine and other essential supplies for civilians caught in the conflict between Israel and Hamas.

Senator Elizabeth Warren has introduced legislation that would prohibit private equity firms from owning medical practices. The bill targets concerns that investor ownership drives up healthcare costs, cuts staffing, and prioritizes profits over patient care. Supporters see it as a push to keep medicine in the hands of clinicians, while critics are expected to argue it limits capital investment in healthcare practices.

Speaking during a visit to the French shrine of Lourdes, Pope Francis said medicine must never become the servant of programmed death, a remark widely read as a rejection of euthanasia and assisted dying. The comments came at one of the Catholic Church's most important pilgrimage sites, which is closely associated with healing and care for the sick.

India has dispatched humanitarian support to Afghanistan, continuing a policy of providing assistance to the Afghan people despite not formally recognising the Taliban administration. The aid is part of New Delhi's ongoing engagement with Afghanistan, which has included wheat, medicines and other relief supplies in recent years. Observers see the move as a sign of India maintaining a humanitarian presence in the region.

Stanford Medicine is reported to have revealed that the human brain functions as two organs rather than a single unified one, according to a broadcast item from KRON 4 that has drawn over 1.3 million likes. The claim suggests a significant reframing of how brain anatomy and function are understood. Further details of the research, its methods, and peer review status have not been provided.

A Stanford Medicine study finds that cutting ultra-processed foods from school menus will be tricky. The research suggests efforts to improve school meal quality face practical obstacles, though details of the findings were not provided. The study adds to ongoing debate about how schools can serve healthier food to students while working within tight budgets and existing supply chains.

Drugs like Ozempic and Wegovy were originally developed and described as obesity treatments for patients with medical need, but they are increasingly marketed and used as lifestyle drugs for customers seeking cosmetic or wellness benefits. Commentators note this reframing raises questions about access for people with genuine medical need, pricing, and how the pharmaceutical industry positions these medicines.

The Council of the European Union has adopted the so-called pharma package, a major revision of the bloc's pharmaceutical legislation aimed at making the sector fairer and more competitive. The reform is intended to modernise rules on medicines' authorisation, availability and affordability across EU member states, and now forms part of the Union's wider health policy agenda.

Researchers at Washington University School of Medicine report that people who use cannabis frequently tend to have more severe epilepsy. The finding, covered by Medical Xpress, suggests heavy marijuana use is associated with worse seizure outcomes, though the relationship between cannabis and epilepsy remains an active area of debate in medical research.

Dozens of Tennessee medical professionals have written to Governor Bill Lee urging that healthcare workers should never take part in executions, regardless of the method. The appeal follows a botched lethal injection in the state in May, which renewed scrutiny of how Tennessee carries out the death penalty. The medical professionals argue that participating in executions violates the ethical obligations of medicine, and they want the governor to commit to keeping clinicians out of the process.

A new study reports that women presenting with symptoms similar to men's often receive less intensive medical care. The findings point to possible disparities in how treatment decisions are made in hospitals, echoing long-running concerns about gender bias in medicine. Researchers and commentators say the results underline the need for clinicians to reassess how urgently women's symptoms are evaluated and treated.

New research suggests donor hearts may take on the biological age of their recipients after transplantation, rather than retaining the age of the original donor. Reported by Scientific American, the finding could reshape how doctors think about organ aging, rejection risk and long-term outcomes for transplant patients.

A growing debate is unfolding over legal responsibility when artificial intelligence systems used in healthcare make errors. As AI tools move into diagnosis and treatment decisions, questions are mounting over whether doctors, hospitals, drugmakers or software developers should be held accountable when a wrong recommendation harms a patient, and regulators have yet to offer clear answers.

Health insurers are warning that the rapid spread of artificial intelligence in medicine could drive billions of dollars in additional healthcare costs, citing the potential for AI-enabled care to expand utilization and billing volumes. Medical billing companies are pushing back, arguing the technology actually reduces administrative expenses and improves efficiency. The dispute highlights a growing divide in the industry over how AI will reshape health spending, with insurers and billing firms offering sharply conflicting forecasts as adoption accelerates across hospitals and physician practices.

A viewpoint published by Chief Healthcare Executive argues that artificial intelligence is already transforming medical practice, and that medical education needs to change accordingly. The piece calls on educators to rethink how future doctors are trained so they can work alongside AI tools. It adds to a growing debate among healthcare leaders about whether curricula are keeping pace with rapid technological change in clinical settings.

GLP-1 weight-loss drugs such as Ozempic and Wegovy are being linked to changes in sleep health, with researchers examining how significant weight loss affects sleep apnoea and other sleep disorders. The trend is prompting sleep medicine specialists to rethink diagnosis rates, treatment demand and how therapies like CPAP may be used as more patients take these medications.

An obesity medicine doctor is addressing the growing trend of microdosing Ozempic, the diabetes drug widely used for weight loss, explaining the safety concerns and potential risks of taking lower-than-standard doses. The doctor notes there are limited situations where a low dose may be appropriate, but warns patients against adjusting medication on their own without medical supervision.

Researchers at Michigan Medicine have published a study presenting a new framework for direct cell reprogramming, the process of converting one cell type into another without passing through a stem cell state. The work could guide future regenerative medicine approaches by clarifying how cell identity can be changed. Details of the findings and their practical implications are still limited in early coverage.

Maternal-fetal medicine specialists have published new clinical standards for managing high-risk pregnancies in states with abortion bans. The guidelines aim to clarify when interventions are legally permissible and medically necessary, addressing confusion among physicians treating endangered patients. The move responds to reports of delayed or denied care, and is likely to fuel ongoing debate over how restrictive abortion laws affect pregnancy treatment.

Japan is considering stricter regulations on regenerative medicine as treatments in the field proliferate across the country. The move follows growing concern that clinics are offering unproven therapies under looser rules than those governing conventional drugs. Officials are debating how to balance patient access to innovative treatments with safety oversight, and medical groups are watching closely for what the revised framework could mean for practice.

A functional medicine expert is cautioning that high doses of GLP-1 weight-loss and diabetes drugs may affect more than appetite, potentially disrupting other bodily processes beyond food cravings. The warning, reported by Fox News, adds to ongoing debate about the safety and long-term effects of medications such as Ozempic and Wegovy as their use continues to expand.